These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 29652673)

  • 1. Inflammation and coronary artery disease: from pathophysiology to Canakinumab Anti-Inflammatory Thrombosis Outcomes Study (CANTOS).
    Ali M; Girgis S; Hassan A; Rudick S; Becker RC
    Coron Artery Dis; 2018 Aug; 29(5):429-437. PubMed ID: 29652673
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inflammation and Atherosclerosis: The End of a Controversy.
    Hansson GK
    Circulation; 2017 Nov; 136(20):1875-1877. PubMed ID: 28916641
    [No Abstract]   [Full Text] [Related]  

  • 3. Addressing Acute Coronary Syndromes: New Challenges and Opportunities After the CANTOS Trial (Canakinumab Anti-inflammatory Thrombosis Outcomes Study).
    Crea F; Liuzzo G
    Circulation; 2018 Mar; 137(11):1100-1102. PubMed ID: 29530890
    [No Abstract]   [Full Text] [Related]  

  • 4. Inflammation and cardiovascular diseases: lessons from seminal clinical trials.
    Liberale L; Montecucco F; Schwarz L; Lüscher TF; Camici GG
    Cardiovasc Res; 2021 Jan; 117(2):411-422. PubMed ID: 32666079
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of vascular inflammation in coronary artery disease: potential of anti-inflammatory drugs in the prevention of atherothrombosis. Inflammation and anti-inflammatory drugs in coronary artery disease.
    Moreira DM; da Silva RL; Vieira JL; Fattah T; Lueneberg ME; Gottschall CA
    Am J Cardiovasc Drugs; 2015 Feb; 15(1):1-11. PubMed ID: 25369900
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interplay between hypercholesterolaemia and inflammation in atherosclerosis: Translating experimental targets into clinical practice.
    Tuñón J; Bäck M; Badimón L; Bochaton-Piallat ML; Cariou B; Daemen MJ; Egido J; Evans PC; Francis SE; Ketelhuth DF; Lutgens E; Matter CM; Monaco C; Steffens S; Stroes E; Vindis C; Weber C; Hoefer IE;
    Eur J Prev Cardiol; 2018 Jun; 25(9):948-955. PubMed ID: 29759006
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The CANTOS Trial: One Important Step for Clinical Cardiology but a Giant Leap for Vascular Biology.
    Baylis RA; Gomez D; Mallat Z; Pasterkamp G; Owens GK
    Arterioscler Thromb Vasc Biol; 2017 Nov; 37(11):e174-e177. PubMed ID: 28970294
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of inflammation in the pathogenesis of atherosclerosis and therapeutic interventions.
    Raggi P; Genest J; Giles JT; Rayner KJ; Dwivedi G; Beanlands RS; Gupta M
    Atherosclerosis; 2018 Sep; 276():98-108. PubMed ID: 30055326
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of Allergic Inflammatory Cells in Coronary Artery Disease.
    Niccoli G; Montone RA; Sabato V; Crea F
    Circulation; 2018 Oct; 138(16):1736-1748. PubMed ID: 30354461
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A New Perspective for Chinese Medicine Intervention for Coronary Artery Disease: Targeting Inflammation.
    Li SM; Li JG; Xu H
    Chin J Integr Med; 2019 Jan; 25(1):3-8. PubMed ID: 30132247
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Utility of Anti-Inflammatory Agents in Cardiovascular Disease: A Novel Perspective on the Treatment of Atherosclerosis.
    Kottoor SJ; Arora RR
    J Cardiovasc Pharmacol Ther; 2018 Nov; 23(6):483-493. PubMed ID: 29783850
    [TBL] [Abstract][Full Text] [Related]  

  • 12. From clinical observations to molecular mechanisms and back to patients: the successful circuit of the CANTOS study.
    Lembo G
    Cardiovasc Res; 2018 Jan; 114(1):e3-e5. PubMed ID: 29293914
    [No Abstract]   [Full Text] [Related]  

  • 13. Clinician's Guide to Reducing Inflammation to Reduce Atherothrombotic Risk: JACC Review Topic of the Week.
    Ridker PM
    J Am Coll Cardiol; 2018 Dec; 72(25):3320-3331. PubMed ID: 30415883
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mortality Differences Associated With Treatment Responses in CANTOS and FOURIER: Insights and Implications.
    Ridker PM
    Circulation; 2018 Apr; 137(17):1763-1766. PubMed ID: 29273581
    [No Abstract]   [Full Text] [Related]  

  • 15. Editorial: update on inflammatory targets modulating atherogenesis.
    Carbone F; Mach F; Montecucco F
    Curr Drug Targets; 2015; 16(4):282-3. PubMed ID: 25859799
    [No Abstract]   [Full Text] [Related]  

  • 16. Novel anti-inflammatory therapies for the treatment of atherosclerosis.
    Khan R; Spagnoli V; Tardif JC; L'Allier PL
    Atherosclerosis; 2015 Jun; 240(2):497-509. PubMed ID: 25917947
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Update on the Inflammatory Hypothesis of Coronary Artery Disease.
    Boland J; Long C
    Curr Cardiol Rep; 2021 Jan; 23(2):6. PubMed ID: 33409720
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chronic inflammation, cardiometabolic diseases and effects of treatment: Psoriasis as a human model.
    Aksentijevich M; Lateef SS; Anzenberg P; Dey AK; Mehta NN
    Trends Cardiovasc Med; 2020 Nov; 30(8):472-478. PubMed ID: 31837960
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recent advances in therapeutic targeting of inflammation in atherosclerosis.
    Hedin U; Matic LP
    J Vasc Surg; 2019 Mar; 69(3):944-951. PubMed ID: 30591299
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inflammation and atherosclerosis--revisited.
    Pant S; Deshmukh A; Gurumurthy GS; Pothineni NV; Watts TE; Romeo F; Mehta JL
    J Cardiovasc Pharmacol Ther; 2014 Mar; 19(2):170-8. PubMed ID: 24177335
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.